Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction
Mei-Tzu Wang, Sheng‐Che Lin, Pei‐Ling Tang, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project
Mengge Zhou, Jing Liu, Yongchen Hao, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 81
Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
Young Sang Lyu, Seok Kyu Oh, Jin Hwa Kim, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Dipeptidyl peptidase-4 inhibitor decreases the risk of atrial fibrillation in patients with type 2 diabetes: a nationwide cohort study in Taiwan
Chia‐Yu Chang, Yung‐Hsin Yeh, Yi‐Hsin Chan, et al.
Cardiovascular Diabetology (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 58
Comparison of the effect of glucose-lowering agents on the risk of atrial fibrillation: A network meta-analysis
Wence Shi, Wenchang Zhang, Da Zhang, et al.
Heart Rhythm (2021) Vol. 18, Iss. 7, pp. 1090-1096
Closed Access | Times Cited: 38
Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials
Xiaodong Zhuang, Xin He, Daya Yang, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 36
The role of dipeptidylpeptidase-4 inhibitors in management of cardiovascular disease in diabetes; focus on linagliptin
Annayya R. Aroor, Camila Manrique‐Acevedo, Vincent G. DeMarco
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 32
Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging
Fen Cao, Kun Wu, Yongzhi Zhu, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 18
Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary
Zoltán Kiss, György Rokszin, Zsolt Abonyi‐Tóth, et al.
Cardiovascular Diabetology (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 22
Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study
Kyoung Jin Kim, Jimi Choi, Juneyoung Lee, et al.
Cardiovascular Diabetology (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 21
Vildagliptin and G-CSF Improved Angiogenesis and Survival after Acute Myocardial Infarction
Mincai Li, Zexia Wang, Hongli Xia, et al.
Archives of Medical Research (2019) Vol. 50, Iss. 3, pp. 133-141
Closed Access | Times Cited: 21
Sitagliptin therapy improves myocardial perfusion and arteriolar collateralization in chronically ischemic myocardium: A pilot study
Sharif A. Sabe, Dwight D. Harris, Mark Broadwin, et al.
Physiological Reports (2023) Vol. 11, Iss. 11
Open Access | Times Cited: 6
Recent advances in the diagnosis and management of acute myocardial infarction
Yi-Keng Hsieh, Mei-Tzu Wang, Chien‐Ying Wang, et al.
Journal of the Chinese Medical Association (2023)
Open Access | Times Cited: 6
Dipeptidyl peptidase 4 inhibitors attenuate cardiac ischaemia–reperfusion injury in rats with diabetes mellitus type 2
Jovana Bradić, Isidora Milosavljević, Stefani Bolevich, et al.
Clinical and Experimental Pharmacology and Physiology (2020) Vol. 48, Iss. 4, pp. 575-584
Closed Access | Times Cited: 16
Comparison of long-term mortality in patients with acute myocardial infarction associated with or without sepsis
En‐Shao Liu, Cheng‐Hung Chiang, Wang-Ting Hung, et al.
International Journal of Infectious Diseases (2018) Vol. 79, pp. 169-178
Open Access | Times Cited: 16
Resolving inflammatory links between myocardial infarction and vascular dementia
Edward B. Thorp, Margaret E. Flanagan, Brian Popko, et al.
Seminars in Immunology (2022) Vol. 59, pp. 101600-101600
Open Access | Times Cited: 9
Prognostic Value of Hyperglycemia on Admission on In-hospital Outcomes in Patients Presenting with ST-elevation Myocardial Infarction
Muhammad Shahid, Hafiz Muhammad Asif Zarif, Muhammad Shahzad Farid, et al.
Cureus (2020)
Open Access | Times Cited: 12
Application of tirofiban in patients with acute myocardial infarction complicated with diabetes and undergoing emergency interventional therapy
Xiuying Tang, Runjun Li, Lixiang Ma, et al.
Pakistan Journal of Medical Sciences (2021) Vol. 38, Iss. 1
Open Access | Times Cited: 10
Cardioprotective effects of sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase 4 inhibitor in type 2 diabetes: A meta-analysis of comparative safety and efficacy
Abhigan Babu Shrestha, Anupam Halder, Kripa Rajak, et al.
SAGE Open Medicine (2024) Vol. 12
Open Access | Times Cited: 1
Acute coronary syndrome in COVID-19 patients
M. G. Chashchin, A. Yu. Gorshkov, О. М. Драпкина
CARDIOVASCULAR THERAPY AND PREVENTION (2021) Vol. 20, Iss. 5, pp. 2806-2806
Open Access | Times Cited: 9
Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors
Cheng‐Yi Chen, Vin‐Cent Wu, Cheng‐Jui Lin, et al.
Mayo Clinic Proceedings (2018) Vol. 93, Iss. 12, pp. 1760-1774
Open Access | Times Cited: 9
Impact of early intervention with alogliptin on coronary plaque regression and stabilization in patients with acute coronary syndromes
Kozo Okada, Shinnosuke Kikuchi, Shotaro Kuji, et al.
Atherosclerosis (2022) Vol. 360, pp. 1-7
Open Access | Times Cited: 6
Combination Therapy with Dipyridamole and Clopidogrel for Secondary Stroke Prevention in Aspirin-Intolerant Patients After Myocardial Infarction: Results of a Nationwide Case-Control Study
Mei-Tzu Wang, Hsin-Li Liang, Cheng Chung Hung, et al.
CNS Drugs (2019) Vol. 33, Iss. 2, pp. 175-185
Open Access | Times Cited: 8
Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection
Marina Rankovic, Nevena Jeremić, Ivan Srejović, et al.
Heart Failure Reviews (2020) Vol. 26, Iss. 2, pp. 437-450
Closed Access | Times Cited: 8
Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006–2016
Min-Hao Lin, Huang‐Yu Yang, Chieh‐Li Yen, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3578-3578
Open Access | Times Cited: 6
Diabetes mellitus: relation between cardiovascular events and pharmacological treatment.
Cláudio Santos, Sónia Brito‐Costa, Luís Margalho, et al.
PubMed (2023) Vol. 94, Iss. 2, pp. e2023012-e2023012
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top